Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01624584 · ClinicalTrials.gov registry record · Phase 3
A Study Comparing Two Treatments for Child With Anxiety
A Phase 3 study of Anxiety, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 3
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT01624584: Completed Phase 3 study of Anxiety, sponsored by Mayo Clinic.
NCT01624584 is a Phase 3 study of Anxiety that has completed, run by Mayo Clinic. The registered enrollment target is 15 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01624584, a Phase 3 study of Anxiety, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
First, can exposure therapy for childhood anxiety begin earlier in the course of treatment than current treatment manuals suggest? Second, is treating childhood anxiety with exposure therapy more effective and efficient than treating childhood anxiety with relaxation training + cognitive restructuring?
Primary Outcome
Changes in PARS rating from time 1 to time 2 will be compared
Conditions Studied
Interventions
- BEHAVIORAL Experimental treatment
- BEHAVIORAL Traditional Treatment
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2012-06 |
| Est. Completion | 2014-08 |
| Phase | Phase 3 |
What the finished NCT01624584 record still lists
NCT01624584 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Anxiety appearing as the primary indexed condition, and to 2 interventions - of which Experimental treatment is the first listed.
NCT01624584 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT01624584 about?
NCT01624584 is a clinical study titled "A Study Comparing Two Treatments for Child With Anxiety". First, can exposure therapy for childhood anxiety begin earlier in the course of treatment than current treatment manuals suggest? Second, is treating childhood anxiety with exposure therapy more effective and efficient than treating childhood anxiety with relaxation training + cognitive restructur...
What is the current status of trial NCT01624584?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 15 participants. The study started on 2012-06. Estimated completion is 2014-08.
What conditions does trial NCT01624584 study?
This clinical trial studies the following conditions: Anxiety.
What interventions are being tested in trial NCT01624584?
The interventions under investigation include: Experimental treatment (BEHAVIORAL), Traditional Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT01624584?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01624584 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01624584's enrollment target sits among peer trials
15 345th of 364 higher than 18 of 364 other Anxiety trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
REmotely-delivered Supportive Programs for Improving Surgical Pain and disTrEss
RECRUITING · Phase 3
-
P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety
RECRUITING · Phase 3
-
Creatine for Depressed Male and Female Methamphetamine Users
RECRUITING · Phase 3
-
Quetiapine Extended Release (XR) in Bipolar Patients With Comorbid Generalized Anxiety Disorder (GAD)
COMPLETED · Phase 3
-
Randomized Control Trial of an Animal-Assisted Intervention With Adjudicated Youth
COMPLETED · Phase 3
-
Acute and Long-Term Antidepressant Treatment Success in Adolescents With Anxiety (AtLAS-A)
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia